Back | Next |
home / stock / fprx / fprx message board
Subject | By | Source | When |
---|---|---|---|
Morning... another board alerted me to the 'news' of | timberwolf7 | investorshub | 11/11/2020 10:10:13 AM |
Opens 30s | Oger | investorshub | 11/11/2020 4:13:41 AM |
$102 a share, your right | Oger | investorshub | 11/11/2020 1:10:38 AM |
GOOD CALL. $FPRX IS$ NOW 300% UP | otcmoneydoubler | investorshub | 11/11/2020 12:59:21 AM |
$10 2morrow | tiger3 | investorshub | 11/10/2020 11:28:52 PM |
Biotechnology Value Fund just keeps adding so taken | stockguard | investorshub | 12/19/2019 6:52:43 PM |
has earned a spot on tonights trade ideas: msmoneymoves.com/2019/12/02/trade-ide | Zmill | investorshub | 12/04/2019 5:45:11 AM |
* * $FPRX Video Chart 10-09-2019 * * | ClayTrader | investorshub | 10/09/2019 8:34:53 PM |
11:11 on Ash Wednesday go tribe! | Raphael De La Ghetto | investorshub | 03/07/2019 3:38:25 AM |
Two Biotech Companies Rated Strong Buys for the | trendmkr | investorshub | 12/29/2015 8:40:23 PM |
$FPRX recent news/filings | stocktrademan | investorshub | 12/15/2015 7:01:46 PM |
But it's not the type of gap that | Juice Newton | investorshub | 10/19/2015 9:37:46 PM |
Covered short | sorkin | investorshub | 10/19/2015 4:44:34 PM |
Large GAP to close | sorkin | investorshub | 10/19/2015 2:45:26 PM |
$FPRX is in the Loncar Cancer Immunotherapy Index | crudeoil24 | investorshub | 10/17/2015 12:18:38 PM |
Secondaries coming! Check insider transactions | sorkin | investorshub | 10/16/2015 9:17:42 PM |
Nothing stopping this beast! | crudeoil24 | investorshub | 10/16/2015 4:14:57 PM |
Heading to $33.00+ today. | crudeoil24 | investorshub | 10/16/2015 3:15:47 PM |
Shorted @ 27.9 | sorkin | investorshub | 10/16/2015 1:06:57 PM |
Read about the BMY Opdivo AEs here: | north40000 | investorshub | 10/15/2015 3:19:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Five Prime Therapeutics Inc. Company Name:
FPRX Stock Symbol:
NASDAQ Market:
Five Prime Therapeutics Inc. Website:
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics PR Newswire THOUSAND OAKS, Calif. , April 16, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all out...
Amgen (NASDAQ: AMGN) recently announced plans to acquire Five Prime Therapeutics (NASDAQ: FPRX) for approximately $1.9 billion. The deal gives Amgen rights to bemarituzumab, which has made it through phase 2 testing. In this video from Motley Fool Live , recorded on ...
Five Prime Therapeutics, Inc. (NASDAQ: FPRX) announced today that it has canceled its fourth quarter and full year 2020 earnings conference call, which was previously scheduled for Wednesday, March 10, 2021 at 1:30 p.m. PT / 4:30 p.m. ET. The cancellation is the result of the co...